Search

everythinglearnresearchcommunity

for

Search:↓

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Teledermatology could improve skin care access, but its success depends on technology, quality strategies, and payment policies; also, vitamin B12 might help treat a specific hair loss condition.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Narrowband UVB therapy significantly improved a child's rare skin condition.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

The combination treatment showed a higher response rate but no significant survival benefits.

Certain scalp tissue features can predict how well alopecia areata responds to steroid injections.

Topical PUVA and tacrolimus ointment can effectively and safely treat infant alopecia universalis.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.